中国药房2017，Vol.28Issue(22)：3135-3138,4.DOI:10.6039/j.issn.1001-0408.2017.22.30
2011-2015年我国药品监管统计年报分析
Analysis of Drug Regulatory Statistical Yearbooks in China during 2011-2015
祁永飞 1包晗 1邱鹏程 1张鑫磊 1王伟 1王玉琨1
作者信息
摘要
Abstract
OBJECTIVE:To provide reference for strengthening drug regulation in drug administration department. METH-ODS:Drug regulatory statistical yearbooks during 2011-2015 were collected. Literature analysis,content analysis,comparative analysis and secondary analysis were conducted to analyze and explore the drug production license,business license,advertising ap-proval,protection of TCM varieties,drug complaints,investigation and punishment of drug cases,etc. in statistical yearbook. RE-SULTS & CONCLUSIONS:The number of drug manufacturers and operating enterprises had been increasing year by year,while the retail chain stores in certified enterprises showed tendency to go beyond the single retail pharmacy. Compared with the down-ward trend of number of approved drug advertisements,the number of protected varieties of TCM decreased more obviously. The increase in number of drug complaints did not cause the number of investigated and punished drug cases at the same time,which showed a downward trend. It is suggested to further improve the quality and efficiency of drug regulatory work in China by strict drug production license approval,reforming drug advertising regulation and TCM varieties protection system,intensifying efforts to investigate and punish drug complaints and cases,and playing the supervision of public opinion role of the media and the masses.关键词
药品监管/统计年报/分析Key words
Drug regulatory/Statistical yearbook/Analysis分类
医药卫生引用本文复制引用
祁永飞,包晗,邱鹏程,张鑫磊,王伟,王玉琨..2011-2015年我国药品监管统计年报分析[J].中国药房,2017,28(22):3135-3138,4.
